Rho Family Proteins: Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion (adv. Sci. 14/2020)
Zhongya Sun,Hao Zhang,Yuanyuan Zhang,Liping Liao,Wen Zhou,Fengcai Zhang,Fulin Lian,Jing Huang,Pan Xu,Rukang Zhang,Wenchao Lu,Mingrui Zhu,Hongru Tao,Feng Yang,Hong Ding,Shijie Chen,Liping Yue,Bing Zhou,Naixia Zhang,Minjia Tan,Hualiang Jiang,Kaixian Chen,Бо Лю,Chuanpeng Liu,Yongjun Dang,Cheng Luo
DOI: https://doi.org/10.1002/advs.202070079
IF: 15.1
2020-01-01
Advanced Science
Abstract:In article number 2000098, Bo Liu, Chuanpeng Liu, Yongjun Dang, Cheng Luo, and co-workers describe the fi rst covalent and allosteric inhibitors targeting RhoA, which had been deemed as an “undruggable” protein target. This study reveals a novel allosteric regulatory site within the Rho family, which could be exploited for anti-metastasis drug development, and also provides a novel strategy for inhibitor discovery toward “undruggable” proteins.